Enhancement of Antiviral CD8+ T-Cell Responses and Complete Remission of Metastatic Melanoma in an HIV-1-Infected Subject Treated With Pembrolizumab

Journal of Clinical Medicine
doi 10.3390/jcm8122089
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Complete Remission of Metastatic Melanoma With Nivolumab and Complete Remission of Hepatitis C With Ledipasvir

Cancer therapy & Oncology International Journal
2017English

Panhypopituitarism in Metastatic Melanoma Patient Treated With Ipilimumab and Pembrolizumab

Journal of Cutaneous Immunology and Allergy
2019English

CD8+ T Cell Responses in Metastatic Melanoma Patients Receiving an Adenovirally Antigen Engineered Dendritic Cell Vaccine +/- IFN-α

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Purification of a Modified Form of Bovine Antithrombin III as an HIV-1 CD8+T-cell Antiviral Factor

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2002English

Cutaneous CD56 + T-Cell Lymphoma Developing During Pembrolizumab Treatment for Metastatic Melanoma

JAAD Case Reports
Dermatology
2018English

Nef-Specific CD8+ T Cell Responses Contribute to HIV-1 Immune Control

PLoS ONE
Multidisciplinary
2013English

Adaptation of CD8 T Cell Responses to Changing HIV-1 Sequences in a Cohort of HIV-1 Infected Individuals Not Selected for a Certain HLA Allele

PLoS ONE
Multidisciplinary
2013English

Reactivation Kinetics of HIV-1 and Susceptibility of Reactivated Latently Infected CD4+T Cells to HIV-1-Specific CD8+T Cells

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2015English

Modulation of the Strength and Character of HIV-specific CD8+ T Cell Responses With Heteroclitic Peptides

AIDS Research and Therapy
VirologyMolecular MedicinePharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy